AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs
Go back to AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs| ATA, Inc. (NASDAQ: ATAI) | Delayed: 4.09 +0.04 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.05 | 52 Week High | $7.32 | |||
| Open | $3.99 | 52 Week Low | $3.30 | |||
| Day High | $4.11 | P/E | N/A | |||
| Day Low | $3.96 | EPS | $0.00 | |||
| Volume | 611,751 | |||||

